GlassScriptPhysician profile
Douglas R Ewing
NPI 1245397017
$4,321.48
in general payments reported to CMS, 2019-2025
16 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $133 · 2021: $26.49 · 2022: $2,148 · 2023: $614 · 2024: $280 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,996.78 | 2022 | |
| Medtronic, INC. | $712.14 | 2023-2025 | Signia, Progrip, Ligasure |
| Ethicon US, LLC | $614.66 | 2019-2023 | Echelon Flex |
| Covidien LP | $379.33 | 2019-2020 | |
| Davol INC. | $105.72 | 2025 | Avitene Ultrafoam, Channel Drain |
| Novo Nordisk INC | $100.59 | 2023-2025 | Wegovy |
| Ambu INC. | $82.82 | 2025 | |
| Teleflex LLC | $75.67 | 2023-2024 | Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Lilly USA, LLC | $53.24 | 2023-2025 | Zepbound |
| Endo Pharmaceuticals INC. | $44.37 | 2019-2023 | Nascobal |
| Baxter Healthcare | $36.85 | 2025 | Perclot |
| Kerecis Limited | $32.57 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $32.08 | 2024 | Gattex, Eohilia |
| Reshape Lifesciences INC. | $20.61 | 2022 | |
| Boston Scientific Corporation | $19.09 | 2025 | Spyglass Discover |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.